Pannonpharma

What Pannonpharma does

PannonPharma Gyógyszergyártó Kft. is a privately held, fully Hungarian-owned pharmaceutical manufacturer founded in 1995 and headquartered in Pécsvárad, Hungary, with a branch office in Budakalász. The company develops, manufactures, and sells a proprietary portfolio of medicinal products, OTC drugs, medical devices, dietary supplements, and cosmetics across therapeutic categories including respiratory (Diapulmon), dermatology (Ebrimycin, Phlogosam, IRIX, Novascabin), ophthalmology (Taleum eye drops, Septosyl), oral/throat care (Phlogosol), cardiovascular/venous (Dio-PP), pain and fever (Melfen, Miralgin), allergy (Taleum nasal spray), antiviral (Egiferon), and dietary supplement lines (Robodrops, Prostadrops, Choladrops). Its technology base centers on GMP-certified manufacturing of solid dosage forms (tablets, film-coated tablets, hard gelatin capsules, controlled-release formulations, granules, powder mixtures) plus an in-house biotechnology research toolkit spanning in-vitro cell and tissue culture, confocal microscopy, molecular biology (gel electrophoresis, PCR), fermentation, and strain maintenance.

The company holds the rights to primycin (branded Ebrimycin), the only Hungarian original antibiotic, originally reported by Vágyi-Nagy et al. in Nature in 1954 and acquired from Chinoin in 2003; two new patents around primycin are registered. PannonPharma operates three revenue streams: (1) own-brand product sales through Hungarian pharmacy networks and institutional channels, (2) contract manufacturing for external pharmaceutical companies leveraging its GMP-certified facility and clinical trial manufacturing license at the Pécsvárad site, and (3) wholesale pharmaceutical distribution under its GDP certification. Distribution is Hungary-domestic; the company maintains a professional registration portal for doctors and pharmacists and operates as part of a group that includes the Gyógynövény kutató Intézet (GYNKI) medicinal plant research institute. Certifications include pharmaceutical manufacturing and wholesale distribution licenses, GMP, GDP, ISO 9001:2015, and ISO 14001:2015.

The go-to-market is sales-led, targeting healthcare professionals (prescribers, pharmacists) and patients/consumers through pharmacy retail channels, healthcare institutions, content marketing, and a doctor/pharmacist registration system. Operating geographies are limited to Hungary. The company is a member of MAGYOSZ (the Hungarian Association of Pharmaceutical Manufacturers), the Hungarian Biotechnology Association, and the Biotechnológiai Innovációs Bázis (Biotechnology Innovation Base) cluster in South Transdanubia. As of mid-2025, PannonPharma has extended internationally through a research MOU with Oguz Han Engineering and Technology University of Turkmenistan focused on medicinal plant research and nanotechnology.

Name

Pannonpharma

Legal name

PannonPharma Gyógyszergyártó Kft.

Website

https://pannonpharma.hu

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

PannonPharma is a privately held, fully Hungarian-owned pharmaceutical manufacturer founded in 1995 in Pécsvárad, Hungary, producing a proprietary portfolio of OTC and prescription medicines, medical devices, dietary supplements, and cosmetics, and offering GMP-certified contract manufacturing and wholesale distribution services to the Hungarian healthcare market.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Pharmaceutical manufacturing
• OTC medicines
• GMP certified production
• Dietary supplements
• Contract manufacturing

Headquarters

HQ city

Pécsvárad

HQ country

Hungary

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Own Pharmaceutical Products: Development, manufacturing, and sale of proprietary pharmaceutical products including OTC drugs, prescription medications, medical devices, and dietary supplements. Product categories span respiratory, dermatological, cardiovascular, ophthalmological, urogenital, and general wellness applications.
2. Contract Manufacturing: Bespoke pharmaceutical manufacturing services for external clients, leveraging GMP-certified facilities and expertise.
3. Pharmaceutical Analysis and R&D Services: Pharmaceutical analytical services, drug development research, and quality improvement services for healthcare professionals and institutions.
4. Pharmaceutical Wholesale Distribution: Wholesale distribution of pharmaceutical products with GDP certification for proper storage and logistics.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Pannonpharma manufactures a portfolio of pharmaceutical products including OTC drugs, prescription medications, medical devices, dietary supplements, and cosmetics at its GMP-certified facility in Pécsvárad, Hungary. In parallel with branded product manufacturing, the company offers contract manufacturing services to other pharmaceutical firms and provides R&D and pharmaceutical analytical services to industry and research institutions.

Product overview

PannonPharma is a Hungarian pharmaceutical company offering a diverse portfolio of medicinal products, dietary supplements, medical devices, and cosmetics. The product portfolio spans multiple therapeutic categories including: dermatological products (Ebrimycin® gel, Phlogosam® ointment), respiratory treatments (Diapulmon® inhalational drops), ophthalmic products (Taleum® eye drops, Septosyl® eye ointment), oral/throat care (Phlogosol® solution), cardiovascular/venous products (Dio-PP® tablets), pain/fever relief (Melfen®, Miralgin®), allergy treatments (Taleum® nasal spray), and dietary supplements (Robodrops®, Prostadrops®, Choladrops®). The company also manufactures medical devices including Plastubol-PP® wound spray and MommEez® cooling gel patches, as well as cosmetic products like IRIX® spray for skin care. The products are primarily distributed in Hungary with some having dedicated product websites.

Differentiator

Problem solved

Functional benefit

Products and services

• Diapulmon® inhalation drops

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Oguz Han Engineering and Technology University of TurkmenistancoreStrategic or Co-development Partner · 12 June 2025Memorandum of Understanding signed between PannonPharma/GYNKI and the university for educational, research, knowledge transfer, and staff exchange programs. The university is primarily interested in medicinal plant research and nanotechnology. The signing ceremony was broadcast on Turkmen national television and approved by President Serdar Berdimuhamedow.
• Gyógynövénykutató Intézet (GYNKI - Medicinal Plant Research Institute)coreStrategic or Co-development PartnerLong-standing partnership with the Medicinal Plant Research Institute as part of the PannonPharma group. Collaboration on exploiting untapped potential in plants and medicinal herbs. The institute's scientific director Dr. Virág Eszter participated in international conferences and negotiations.
• Magyar Biotechnológiai Szövetség (Hungarian Biotechnology Association)minorStrategic or Co-development PartnerPannonPharma Kft. is a member of the Hungarian Biotechnology Association, connecting the company with the broader biotechnology industry ecosystem.
• Biotechnológiai Innovációs Bázis (Biotechnology Innovation Base Cluster)minorStrategic or Co-development PartnerAccredited cluster operating in the South Transdanubia region of Hungary, providing networking and collaboration opportunities with regional biotechnology stakeholders.
• KKV Trade Kft.minorImplementation/ SI/ Consulting PartnerComplaints handling partner for PannonPharma. Customers can report complaints to KKV Trade Kft. at +36-72/998-645 or [email protected]. Physical complaint office located at H-7623, Pécs, Hőgyes Endre utca 20.
• MAGYOSZ (Magyarországi Gyógyszergyártók Országos Szövetsége - Hungarian Association of Pharmaceutical Manufacturers)minorStrategic or Co-development PartnerPannonPharma is a member company committed to ethical behavior, communication, and transparent operations. As a member, the company adheres to the Generic Transparency Code jointly signed by MAGYOSZ and the Generic Manufacturers and Distributors Association.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Regional players

• KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with broad CEE distribution, including Hungary. Comparable product categories (generic Rx, OTC, animal health) and competes directly in Hungarian pharmacy channels, though headquartered outside Hungary.
• Polpharma: Polish pharmaceutical manufacturer of generic Rx, OTC, and APIs, with significant CEE export reach. Comparable business model as a mid-sized CEE generics and branded manufacturer serving regional markets; not Hungary-based but a direct competitor in the same customer base.

Direct peers

• Gedeon Richter: Hungary's largest pharmaceutical manufacturer, headquartered in Budapest, producing branded, generic, and OTC medicines plus active ingredients. Directly comparable as a Hungary-based pharma manufacturer with a broad Rx/OTC portfolio, but at materially larger scale than PannonPharma.
• Zentiva: Central European (Czech-headquartered) generics manufacturer with a strong presence across CEE including Hungary, producing generic Rx and OTC. Direct peer in the regional generic pharma space that PannonPharma competes with on Hungarian pharmacy shelves.
• ExtractumPharma: Hungarian pharmaceutical contract manufacturer and developer of generic solid and semi-solid dosage forms with GMP certification. Direct match to PannonPharma's contract manufacturing business model and target client base.
• Egis Pharmaceuticals: Hungarian pharmaceutical manufacturer (part of Servier group) producing generic and branded Rx, OTC, and consumer health products across cardiovascular, CNS, and respiratory. Closely comparable as a domestic Hungarian pharma peer serving the same pharmacy channels with a similar product breadth.
• Meditop Pharmaceutical: Hungarian pharmaceutical company manufacturing and distributing generic and branded medicines, dietary supplements, and medical devices. Similar scale and product mix — domestic manufacturer supplying Hungarian pharmacy and hospital channels.

Broad incumbents

• Teva Pharmaceutical Industries: Global generic pharmaceutical major with substantial operations in Hungary. Competes with PannonPharma in generic Rx categories (e.g., ibuprofen, paracetamol) at the same Hungarian pharmacy channel but at vastly greater scale and portfolio breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pannonpharma-ltd
• Facebookfacebook.com/pannonpharma

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pannonpharma